Trader’s Buzz: Flamel Technologies (FLML), Aegerion Pharmaceuticals (AEGR), Home Loan Servicing Solutions (HLSS)

Shares of Flamel Technologies SA (FLML) are down by 41% to $11.08 in late trading on Wednesday, as the stock continues to see loses following the FDA’s approval of Fresenius Kabi’s New Drug Application for neostigmine methylsulfate, a drug which Flamel currently markets as Bloxiverz. Another news that is putting more pressure on Flamel’s shares […] View the full post at: Trader’s Buzz: Flamel Technologies (FLML), Aegerion Pharmaceuticals (AEGR), Home Loan Servicing Solutions (HLSS) Related posts: SEC proposes identification for fast traders Existing Home Sales Plummet Atlas Pipeline (APL) Shares Soar On Nat Gas Asset Sale